FLAD1

flavin adenine dinucleotide synthetase 1

Basic information

Region (hg38): 1:154983338-154993111

Links

ENSG00000160688NCBI:80308OMIM:610595HGNC:24671Uniprot:Q8NFF5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
  • myopathy with abnormal lipid metabolism (Strong), mode of inheritance: AR
  • myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
  • myopathy with abnormal lipid metabolism (Definitive), mode of inheritance: AR
  • myopathy with abnormal lipid metabolism (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Lipid storage myopathy due to FLAD1 deficiencyARBiochemical; CardiovascularIndividuals have shown clinical improvement with dietary management (riboflavin); The condition has been described with cardiomyopathy, and awareness may allow prompt diagnosis and management (eg, with medical management and ICD)Biochemical; Cardiovascular; Neurologic25058219; 27259049

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FLAD1 gene.

  • not_provided (261 variants)
  • Inborn_genetic_diseases (70 variants)
  • Myopathy_with_abnormal_lipid_metabolism (16 variants)
  • FLAD1-related_disorder (10 variants)
  • Multiple_acyl-CoA_dehydrogenase_deficiency (10 variants)
  • not_specified (9 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLAD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000025207.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
81
clinvar
1
clinvar
83
missense
1
clinvar
1
clinvar
147
clinvar
14
clinvar
163
nonsense
6
clinvar
1
clinvar
1
clinvar
8
start loss
0
frameshift
12
clinvar
3
clinvar
1
clinvar
16
splice donor/acceptor (+/-2bp)
4
clinvar
4
Total 19 9 150 95 1

Highest pathogenic variant AF is 0.000024163568

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FLAD1protein_codingprotein_codingENST00000292180 79774
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.009360.9901257060421257480.000167
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5813063360.9110.00001903728
Missense in Polyphen92103.660.887551144
Synonymous1.721111370.8120.000007021273
Loss of Function3.07824.40.3280.00000131271

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004160.000416
Ashkenazi Jewish0.0002020.000198
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001940.000193
Middle Eastern0.00005440.0000544
South Asian0.0001630.000163
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:27259049}.;
Disease
DISEASE: Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency (LSMFLAD) [MIM:255100]: An autosomal recessive, inborn error of metabolism characterized by variable mitochondrial dysfunction. Clinical features range from severe cardiac and respiratory insufficiency with onset in infancy and resulting in early death, to mild muscle weakness with onset in adulthood. Some patients show significant improvement with riboflavin treatment. Analysis of skeletal muscle show multiple mitochondrial respiratory chain deficiency and a lipid storage myopathy in most patients. {ECO:0000269|PubMed:27259049}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Riboflavin metabolism - Homo sapiens (human);Riboflavin Metabolism;Selenium Micronutrient Network;Folate Metabolism;Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;flavin biosynthesis (Consensus)

Recessive Scores

pRec
0.232

Intolerance Scores

loftool
0.0672
rvis_EVS
-1.04
rvis_percentile_EVS
7.71

Haploinsufficiency Scores

pHI
0.114
hipred
N
hipred_score
0.371
ghis
0.639

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.999

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Flad1
Phenotype

Gene ontology

Biological process
FAD biosynthetic process;riboflavin metabolic process
Cellular component
mitochondrial matrix;cytosol;plasma membrane
Molecular function
FMN adenylyltransferase activity;protein binding;ATP binding